These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7932545)

  • 1. (+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model.
    Koch K; Melvin LS; Reiter LA; Biggers MS; Showell HJ; Griffiths RJ; Pettipher ER; Cheng JB; Milici AJ; Breslow R
    J Med Chem; 1994 Sep; 37(20):3197-9. PubMed ID: 7932545
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist.
    Djuric SW; Collins PW; Jones PH; Shone RL; Tsai BS; Fretland DJ; Butchko GM; Villani-Price D; Keith RH; Zemaitis JM
    J Med Chem; 1989 Jun; 32(6):1145-7. PubMed ID: 2542550
    [No Abstract]   [Full Text] [Related]  

  • 5. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
    Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
    J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930.
    Penning TD; Djuric SW; Docter SH; Yu SS; Spangler D; Anglin CP; Fretland DJ; Kachur JF; Keith RH; Tsai BS
    Agents Actions; 1993; 39 Spec No():C11-3. PubMed ID: 8273545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
    Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
    Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
    J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4.
    Lefebvre JS; Lévesque T; Picard S; Paré G; Gravel A; Flamand L; Borgeat P
    Arthritis Rheum; 2011 Jun; 63(6):1527-33. PubMed ID: 21360520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.
    Liston TE; Conklyn MJ; Houser J; Wilner KD; Johnson A; Apseloff G; Whitacre C; Showell HJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):115-21. PubMed ID: 9491823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical isomers of a leukotriene B4 antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis.
    Fretland DJ; Widomski DL; Anglin CP; Yu S; Djuric SW
    Chirality; 1992; 4(6):353-5. PubMed ID: 1333259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats.
    Souza DG; Coutinho SF; Silveira MR; Cara DC; Teixeira MM
    Eur J Pharmacol; 2000 Sep; 403(1-2):121-8. PubMed ID: 10969152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.
    Turner CR; Breslow R; Conklyn MJ; Andresen CJ; Patterson DK; Lopez-Anaya A; Owens B; Lee P; Watson JW; Showell HJ
    J Clin Invest; 1996 Jan; 97(2):381-7. PubMed ID: 8567958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
    Lin AH; Morris J; Wishka DG; Gorman RR
    Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.
    Matsukawa A; Hogaboam CM; Lukacs NW; Lincoln PM; Strieter RM; Kunkel SL
    J Immunol; 1999 Dec; 163(11):6148-54. PubMed ID: 10570305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.
    Gladue RP; Carroll LA; Milici AJ; Scampoli DN; Stukenbrok HA; Pettipher ER; Salter ED; Contillo L; Showell HJ
    J Exp Med; 1996 Apr; 183(4):1893-8. PubMed ID: 8666945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
    Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.